Logo

Late-onset protracted febrile myalgia syndrome successfully treated with colchicine owing to heterozygous MEFV exon 2 variants

1, 2, 3, 4, 5, 6

  1. Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Medical Sciences, Japan.
  2. Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Medical Sciences, Japan. tkoga@nagasaki-u.ac.jp
  3. Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Medical Sciences, Japan.
  4. Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Medical Sciences, Japan.
  5. Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Medical Sciences, Japan.
  6. Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Medical Sciences, Japan.

CER12277 Submission on line
2019 Vol.37, N°121 ,Suppl.121 - PI 0166
Letters to the Editor

Free to view (click on article PDF icon to read the article)

Rheumatology Article

 

PMID: 31498076 [PubMed]

Received: 27/03/2019 - Accepted : 03/06/2019 - In Press: 22/07/2019 - Published: 09/12/2019